Cellectis
Allogeneic, Gene editing, Genome Engineering, Life sciences, off-the-shef CART therapies, Oncology, T-Cell therapies
Allogeneic, Gene editing, Genome Engineering, Life sciences, off-the-shef CART therapies, Oncology, T-Cell therapies
Cellectis was incorporated in 1999 and is located in Paris, France. The company specialises in Allogeneic, Gene editing, Genome Engineering, Life sciences, off-the-shef CART therapies, Oncology, T-Cell therapies with an estimated revenue and employee in the range of $10 to $50 million and 51-200 respectively.
We have 151 contacts in our database, out of which 32% are decision makers. The distribution of leads are as follows:
In September, 2019 cellectis.com's total website visitor was 14086, declined by 37% from previous month. Some key metrics are Average time spent on site is 6 minutes, Bounce Rate is 65% and average page per visit is 3 respectively.
We Verified cellectis.com server for email deliverability.
Harvest Health & Recreation has acquired Franklin Labs, LLC, a subsidiary of CannaPharmacy, f...
Microsoft today declared that it has acquired Affirmed Networks, an organization that specializes...
Perficient acquires Catalyst Networks, a Georgia corporation doing business as Brainjocks, which ...
Cognizant enters into an agreement to acquire the U.S.-based digital marketing consultancy Lev fo...
© Copyright 2014-2020 by GetCompanyInfo.com. All Rights Reserved.
